PMV Pharmaceuticals, Inc. (PMVP) › Operating Cash FlowPMV Pharmaceuticals, Inc. (PMVP) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$15.18M2019: -$22.07M2020: -$32.74M2021: -$46.57M2022: -$63.76M2023: -$55.66M2024: -$51.28M2025: -$73.58M-$73.58M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$73.58M-43.5%2024-$51.28M+7.9%2023-$55.66M+12.7%2022-$63.76M-36.9%2021-$46.57M-42.2%2020-$32.74M-48.4%2019-$22.07M-45.4%2018-$15.18M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share